vimarsana.com
Home
Live Updates
FDA Releases Guidance on Submissions for AI/ML-Enabled Devic
FDA Releases Guidance on Submissions for AI/ML-Enabled Devic
FDA Releases Guidance on Submissions for AI/ML-Enabled Devices | Foley Hoag LLP
On April 3, 2023, the Food and Drug Administration (FDA) published in the Federal Register an announcement of availability for the draft guidance, Marketing Submission Recommendations...
Related Keywords
,
Foley Hoag ,
Drug Administration ,
Device Software Functions ,
Device Software Function ,
Predetermined Change Control Protocols ,
Federal Register ,
Marketing Submission Recommendations ,
Predetermined Change Control Plan ,
Machine Learning ,
Enabled Device Software Functions ,
Medical Device ,
Proposed Regulatory Framework ,
Based Software ,
Discussion Paper ,
Medical Device Action Plan ,
Reauthorization Act ,
Modification Protocol ,
Software Function ,
Machine Learning Enabled Device Software Function ,
Change Control ,
Authorized Predetermined Change Control Plan ,
Impact Assessment ,
Covered Modifications ,
Premarket Approval ,
Deciding When ,
Software Change ,
Existing Device ,
Devices Subject ,
Decision Making Process ,
Quality System ,